A 24-week Open-label Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

Summary

The purpose of this study is to evaluate the safety, efficacy, and pharmacokinetics of KPS-0373 in SCD patients (Experience of clinical trials of KPS-0373)

Timeline

Start

—

Primary completion

2014-10

Completion

—

Drugs

Indications